We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes (GALILEO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02556203
Recruitment Status : Recruiting
First Posted : September 22, 2015
Last Update Posted : February 15, 2018
Janssen Research & Development, LLC
Information provided by (Responsible Party):